Igroton en es it fr

Igroton Brand names, Igroton Analogs

Igroton Brand Names Mixture

  • Tenoretic (chlorthalidone + atenolol)

Igroton Chemical_Formula

C14H11ClN2O4S

Igroton RX_link

http://www.rxlist.com/cgi/generic3/chlorthalidone.htm

Igroton fda sheet

Igroton msds (material safety sheet)

Igroton Synthesis Reference

Graf et al.; Helv. Chem.; Acta 42; 1085 (1959); U.S.Pat.3,055,904 (1962)

Igroton Molecular Weight

338.767 g/mol

Igroton Melting Point

218-264oC

Igroton H2O Solubility

120 mg/L

Igroton State

Solid

Igroton LogP

1.718

Igroton Dosage Forms

Tablet

Igroton Indication

For management of hypertension either as the sole therapeutic agent or to enhance the effect of other antihypertensive drugs in the more severe forms of hypertension.

Igroton Pharmacology

Chlorthalidone, a monosulfonamyl diuretic, differs form other thiazide diuretics in that a double ring system is incorporated into its structure. Chlorthalidone is used alone or with atenolol in the management of hypertension and edema.

Igroton Absorption

Absorbed relatively rapidly after oral administration.

Igroton side effects and Toxicity

Symptoms of overdose include nausea, weakness, dizziness and disturbances of electrolyte balance.

Igroton Patient Information

Patients should inform their physician if they have: (1) had an allergic reaction to chlorthalidone or other diuretics or have asthma, (2) kidney disease, (3) liver disease, (4) gout, (5) systemic lupus erythematosus, or (6) been taking other drugs such as cortisone, digitalis, lithium carbonate, or drugs for diabetes.

Patients should be cautioned to contact their physician if they experience any of the following symptoms of potassium loss: excess thirst, tiredness, drowsiness, restlessness, muscle pains or cramps, nausea, vomiting, or increased heart rate or pulse.

Patients should also be cautioned that taking alcohol can increase the chance of dizziness occurring.

Igroton Organisms Affected

Humans and other mammals